Preview

EMERGENCY MEDICAL CARE

Advanced search

EXPERIENCE WITH THE USE OF RECOMBINANT SUPEROXIDE DISMUTASE IN THE COMPLEX TREATMENT OF PATIENTS WITH POSTHYPOXIC ENCEPHALOPATHY

https://doi.org/10.24884/2072-6716-2020-21-1-35-42

Abstract

Objective: to study the effect of recombinant superoxide dismutase, included in the complex intensive care, on the antioxidant properties of the blood of patients with acute posthypoxic encephalopathy syndrome.

Material and methods. The study included 34 patients who were treated in the intensive care unit with a diagnosis of acute posthypoxic encephalopathy. Group 1 (n=21) was represented by patients who underwent standard intensive care. In group 2 (n=13), the treatment was supplemented with recombinant superoxide dismutase, administered intravenously with a drug dispenser at a dose of 12.8 million units within 12 hours. Consciousness was evaluated on a scale of Glasgow com and activation — sedation on a scale of Richmond. Spontaneous and induced biochemoluminescence (BCL) of whole venous blood was determined.

Results: In patients of group 2 the phenomena of posthypoxic encephalopathy stopped faster than in group 1. In group 2, all patients were extubated 24 hours after the start of respiratory support, in group 1–57% of patients were extubated after 24 hours, the rest 48 hours after the start of treatment. By the end of the first day, in patients of group 1, spontaneous and induced venous blood BCL considerably increased, significantly exceeding the control values. In group 2, spontaneous venous blood BCL by the end of the first day of intensive care was, on average, lower than in patients of group 1 by 43, 85%, and induced by 52, 49% (p<0.05). By the end of the second day, spontaneous blood BCL in group 2, on average, was lower than in group 1 by 9.2%, and induced by 77.9% (p<0.05). 

Conclusion. Intravenous continuous infusion of recombinant superoxide dismutase, at a dose of 12.8 million units, included in the complex intensive care for patients with posthypoxic encephalopathy, reduces the free radical activity of whole venous blood. A decrease in the free radical activity of blood correlates with a decrease in the manifestations of acute posthypoxic encephalopathy. 

About the Authors

B. N. Shah
St. Petersburg State University
Russian Federation
St. Petersburg



V. A. Volchkov
St. Petersburg State University
Russian Federation
St. Petersburg



I. P. Minnullin
Pavlov First St. Petersburg State Medical University
Russian Federation
St. Petersburg



O. D. Alekseeva
Clinical Hospital for War Veterans
Russian Federation
St. Petersburg



S. V. Kovalev
St. Petersburg State University
Russian Federation
St. Petersburg



References

1. Kapoor R., Kalra J., Prasad K. Cardiac depression and сellular injury in hemorrhagic shock and reinfusion: role of free radicals // Mol. Cell. Biohem. 1997. Vol. 176, Nо 11. Р. 291–301.

2. Lysko A. I., Dudchenko A. M. Reperfuzionnoe povrezhdenie i fenomen «no reflow», rol’ superoksidnogo aniona i peroksinitrita. Patogenez, 2014, Vol. 12, Nо 4, рр. 47–51 (In Russ.).

3. Golubev A. M., Moroz V. V., Kuzovlev A. N., Sundukov D. V. Znachenie ishemii­reperfuzii v razvitii ostrogo povrezhdeniya legkih (obzor). Obshchaya reanimatologiya, 2007, Vol. 3, Nо 3, р. 107 (In Russ.).

4. Shah B. N., Lapshin V. N., Teplov V. M., Smirnov D. B., Kyrnyshev A. G. Mekhanizmy razvitiya poliorgannoj nedostatochnosti pri shokogennoj travme: klinicheskij podhod k probleme. Vestnik hirurgii im. I. I. Grekova, 2011, Vol. 170, Nо 6, рр. 93–97 (In Russ.).

5. Batocyrenov B. V., Livanov G. A., Andrianov A. Yu., Vasil’ev S.A., Kuznecov O. A. Osobennosti klinicheskogo techeniya i korrekciya metabolicheskih rasstrojstv u bol’nyh s tyazhyolymi otravleniyami metadonom. Obshchaya reanimatologiya, 2013, Vol. 9, Nо 2, рр. 18–22 (In Russ.).

6. Lyahovich V. V., Vavilin V. A., Zenkov N. K., Lapkin V. Z., Men’shchikova E. B. Vozmozhnosti kompleksnogo ispol’zovaniya antioksidantov i antigipoksantov v eksperimental’noj i klinicheskoj medicine. Byulleten’ SO RAMN, 2005, Vol. 4, Nо 118, рр. 7–12 (In Russ.).

7. Shah B. N., Lapshin V. N., Kyrnyshev A. G., Smirnov D. B., Kravchenko-­Berezhnaya N. R. Metabolicheskie effekty substratnogo antigipoksanta na osnove yantarnoj kisloty. Obshchaya reanimatologiya, 2014, Vol. 10, Nо 1, рр. 33–42 (In Russ.).

8. Val’dman B. M. Obmen adenilovyh nukleotidov i nekotorye mekhanizmy razvitiya tkanevoj gipoksii pri eksperimental’noj termicheskoj travme: avtoref. dis. … kand. med. nauk. Chelyabinsk, 1973. 21 р. (In Russ.).

9. Luk’yanova L.D., Kirova YU.I., Sukoyan G. V. Novoe o signal’nyh mekhanizmah adaptacii k gipoksii i ih roli v sistemnoj regulyacii. Patogenez, 2011, Vol. 9, Nо 3, рр. 4–14 (In Russ.).

10. Chesnokova N. P., Ponukalina E. V., Bizenkova M. N., Afanas’eva G. A. Vozmozhnosti effektivnogo ispol’zovaniya antioksidantov i antigipoksantov v eksperimental’noj i klinicheskoj medicine. Uspekhi sovremennogo estestvoznaniya, 2006, Nо 8, рр. 18–25 (In Russ.).

11. Zarubina I. V. Sovremennye predstavleniya o patogeneze gipoksii i ee farmakologicheskoj korrekcii. Obzory po klin. farmakol. i lekcii po terapii, 2011, Vol. 9, Nо 3, рр. 31–48 (In Russ.).

12. Okovityj S. V. Klinicheskaya farmakologiya antigipoksantov. FARMindeks-Praktik, 2005, Vyp. 7, рр. 48–63 (In Russ.).

13. Maksimovich N. E., Dremza I. K., Troyan E. I., Maksimovich E. N. Redoks — sostoyanie golovnogo mozga krys v usloviyah ego ishemii — reperfuzii i vvedeniya acetilcisteina. Medicinskij al’manah, 2013, Nо 3 (27), рр. 188–189 (In Russ.).

14. Gvozdev I. I., Savchenko A. A., Borisov A. G., Cherdancev D. V., Pervova O. V., Shapkina V. A. Aktivnost’ respiratornogo vzryva nejtrofil’nyh granulocitov krovi u bol’nyh pri raznoj stepeni tyazhesti rasprostranennogo gnojnogo peritonita // Slozhnye sistemy v ekstremal’nyh usloviyah. Tezisy dokladov XVIII Vserossijskogo simpoziuma s mezhdunarodnym uchastiem. Sibirskij federal’nyj universitet; Institut ekonomiki, upravleniya i prirodopol’zovaniya. Krasnoyarsk, 2016, р. 25 (In Russ.).

15. Shilov V. V., Aleksandrov M. V., Vasil’ev S.A. et al. Toksicheskaya encefalopatiya: opredelenie, klassifikaciya. Vestnik Rossijskoj Voenno-medicinskoj akademii, 2008, Nо 1, рр. 22–27 (In Russ.).

16. Alekseev V. N., Korelina V. E. Nejroprotekciya novym antioksidantom reksod pri eksperimental’noj glaukome. Rossijskij medicinskij zhurnal, 2008, Vol. 9, Nо 3, рр. 82–83 (In Russ.).

17. Barcho A. A., Bguasheva R. I., Bagov A. N., Savenko A. V. Issledovanie cerebroprotektivnyh svojstv meksidola i reksoda v usloviyah ishemii — reperfuzii vnutrennih organov i skeletnyh myshc. Sovremennye problemy nauki i obrazovaniya, 2006, Nо 3, рр. 44–45 (In Russ.).

18. Petrov V. I., Ponomarev E. A., Maskin S. S., Strepetov N. N. Vliyanie farmakologicheskoj nejroprotekcii na stepen’ povrezhdeniya golovnogo mozga pri ishemii­reperfuzii v eksperimente. Eksperimental’naya i klinicheskaya farmakologiya, 2011, Vol. 74, Nо 8, рр. 13–16 (In Russ.).

19. Akimov G. A., Erohina L. G., Stykan O. A. Nevrologiya sinkopal’nyh sostoyanij. Moscow, 1987, 206 р. (In Russ.).

20. Kondrat’ev A. N. Nejrotravma glazami anesteziologa-reanimatologa. Moscow: Medicina, 2014, 203 р. (In Russ.).

21. Shah B. N. Diagnostika i korrekciya narushenij gomeostaza u postradavshih s mekhanicheskoj shokogennoj travmoj v ostrom periode travmaticheskoj bolezni: dis. … d.m.n. Saint Petersburg, 2006. 213 р. (In Russ.).

22. Potievskaya V. I., Gridchik I. E., Grican A. I. et al. Sedaciya pacientov v otdeleniyah reanimacii i intensivnoj terapii (Klinicheskie rekomendacii FAR). Anesteziologiya i reanimatologiya, 2018, Vol. 63, Nо 2, рр. 165–169 (In Russ.).

23. MacIntyre N.R., Cook D. J., Ely W. E., Epstein S. K., Fink J. B., Heffner J. E., Hess D., Hubmayer R. D., Scheinhorn D. J. Evidence­Based Guidelines for Weaning and Discontinuing Ventilatory Support // Chest. 2001. Vol. 120, Nо 6. Р. 375–395.

24. Meade M., Guyatt G., Cook D. J., Griffith L., Sinuff T., Kergl C., Mancebo J., Esteban A., Epstein S. Predicting Success in Weaning from Mechanical Ventilation // Chest. 2001. Vol. 120. Р. 400–424.

25. Popugaev K. A., Savin I. A., Goryachev A. S., Sokolova E. Yu., Oshorov A. V., Polupan A. A., Sychev A. A., Tabasaranskij T. F. Shkala ocenki tyazhesti dyhatel’noj nedostatochnosti u nejrohirurgicheskih pacientov. Anesteziologiya i reanimatologiya, 2010, Nо 4, рр. 42–50 (In Russ.).

26. Grap M. J., Brophy G. M., Sessler C. N. Multidisciplinary management of sedation and analgesia in critical care // Semin. Respir. Crit. Care Med. 2001. Vol. 22, Nо 2. Р. 211–226.

27. Bagnenko S. F., Sinenchenko G. I., Kurygin A. A., Chupris V. G. Korrekciya reperfuzionnoj disfunkcii pri ostroj kishechnoj neprohodimosti. Vestnik hirurgii im. I. I. Grekova, 2008, Vol. 167, Nо 4, рр. 32–35 (In Russ.).


Review

For citations:


Shah B.N., Volchkov V.A., Minnullin I.P., Alekseeva O.D., Kovalev S.V. EXPERIENCE WITH THE USE OF RECOMBINANT SUPEROXIDE DISMUTASE IN THE COMPLEX TREATMENT OF PATIENTS WITH POSTHYPOXIC ENCEPHALOPATHY. EMERGENCY MEDICAL CARE. 2020;21(1):35-42. (In Russ.) https://doi.org/10.24884/2072-6716-2020-21-1-35-42

Views: 516


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2072-6716 (Print)